Neoadjuvant SBRT followed by evorpacept and pembrolizumab in HPV-mediated head and neck squamous cell carcinoma: Investigation of pathologic response.

Joseph A. Califano, R. Bryan Bell, Robert Saddawi‐Konefka et al.|Journal of Clinical Oncology|2025

Cited by 0